NimaGen BV is a whole owned subsidiary and sister business of Biolegio BV, a leading European based custom Oligonucleotide synthesis company.

NimaGen specializes in life sciences applications for R&D and diagnostics for the Molecular Biology sector, with a focus on solutions for Sanger and Next Generation sequencing.

For routine Next Generation DNA Sequencing NimaGen offer two novel target enrichment systems :

The Nimagen EasySeq™ NGS Targeted Capture System, utilises single molecule Molecular Inversion Probes (smMIPs) to offers numerous advantages over existing target capture systems, with no need for DNA fragmentation, no magnetic bead pull-down and a single amplification step, the method is both time and cost effective.

This year the EasySeq™ NGS portfolio was expanded with the introduction of EasySeq™ NGS RC-PCR, a unique multiplex Amplicon sequencing library preparation method, with combined target amplification and NGS indexing in a single PCR. This innovative solution offers the safest, simplest and fastest Amplicon sequencing method available and eliminates the contamination risks associated with conventional methods.

Visit www.biolegio.com & www.nimagen.com